SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

Cell. 2022 Mar 3;185(5):847-859.e11. doi: 10.1016/j.cell.2022.01.015. Epub 2022 Jan 24.

Abstract

We address whether T cell responses induced by different vaccine platforms (mRNA-1273, BNT162b2, Ad26.COV2.S, and NVX-CoV2373) cross-recognize early SARS-CoV-2 variants. T cell responses to early variants were preserved across vaccine platforms. By contrast, significant overall decreases were observed for memory B cells and neutralizing antibodies. In subjects ∼6 months post-vaccination, 90% (CD4+) and 87% (CD8+) of memory T cell responses were preserved against variants on average by AIM assay, and 84% (CD4+) and 85% (CD8+) preserved against Omicron. Omicron RBD memory B cell recognition was substantially reduced to 42% compared with other variants. T cell epitope repertoire analysis revealed a median of 11 and 10 spike epitopes recognized by CD4+ and CD8+ T cells, with average preservation > 80% for Omicron. Functional preservation of the majority of T cell responses may play an important role as a second-level defense against diverse variants.

Keywords: B cells; COVID-19 vaccines; Delta; Omicron; SARS-COV-2; T cells; VOC; VOI; epitopes.

MeSH terms

  • Ad26COVS1 / administration & dosage
  • Ad26COVS1 / immunology
  • BNT162 Vaccine / administration & dosage
  • BNT162 Vaccine / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism
  • COVID-19 / pathology
  • COVID-19 / prevention & control
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / immunology*
  • Epitopes / immunology
  • Epitopes, T-Lymphocyte / immunology
  • Humans
  • Memory B Cells / immunology*
  • Memory B Cells / metabolism
  • Memory T Cells / immunology*
  • Memory T Cells / metabolism
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / metabolism
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / immunology
  • Vaccination

Substances

  • Ad26COVS1
  • COVID-19 Vaccines
  • Epitopes
  • Epitopes, T-Lymphocyte
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • NVX-CoV2373 adjuvated lipid nanoparticle
  • BNT162 Vaccine

Supplementary concepts

  • SARS-CoV-2 variants